Effect of cinacalcet on cardiovascular disease in patients undergoing dialysis

New England Journal of Medicine

Volumn 367, Issue 26, 2012, Pages 2482-2494

  Block, G A ^a   Correa Rotter, R ^a   Drueke T B ^a   Floege, J ^a   Goodman, W G ^a   Herzog, C A ^a   Kubo, Y ^a   London, G M ^a   Mahaffey, K W ^a   Mix, T C ^a   Moe, S M ^a   Trotman, M L ^a   Wheeler, D C ^a   Parfrey, P S ^a   Chertow, G ^a   Hennekens, C ^a   Baigent, C ^a   Brown, W ^a   O'brien, P ^a   Anderson, S ^a   Hoel, J ^a   Szczech, L ^a   Patel, U ^a   Wampole, J ^a   Pun, P ^a   Felker, M ^a   Inrig, J ^a   Shah, S ^a   Hernandez, A ^a   Patel, C ^a   Brennan, M ^a   Albizem, M ^a   Capper, E ^a   Cauchi, L ^a   Cheng, S ^a   Dehmel, B ^a   Dhami, K ^a   Durham, C ^a   Francioni, M ^a   Gadd, S ^a   Goodman, B ^a   Guimaraes, L ^a   Grey, N ^a   Hamlin, R ^a   Harris, C ^a   Harris, E ^a   Heavey, S ^a   Heiges, T ^a   Heiser, D ^a   Jaeger, P ^a   James, M ^a   James, P ^a   Karimi, S ^a   Kewalramani, R ^a   Kraszewski, A ^a   Liang, J ^a   Maguire, J ^a   McCormick, K ^a   McFarlane, K ^a   Modafferi, D ^a   Prathikanti, R ^a   Ryan, C ^a   Santiago, N ^a   Schumacher, J ^a   Seder, C ^a   Shahinfar, S ^a   Soares, B ^a   Stolman, D ^a   Tisher, C ^a   Tseng, S ^a   Ulias, G ^a   Unger, P ^a   Vyshenskaya, A ^a   Walsh, L ^a   White, C ^a   Wilde, K ^a   Santos, J ^a   Zarazaga, C ^a   Marin, I ^a   Garrote, N ^a   Cusumano, A ^a   Penalba, N ^a   Del Valle, E ^a   Juncos, L ^a   Saye, J ^a   Lef, L ^a   Altobelli, V ^a   Petraglia, G ^a   Rosa Diez, G ^a   Douthat, W ^a   Lobo, J ^a   Gallart, C ^a   Lafalla, A ^a   Diez, G ^a   Linares, B ^a   Lopez, N ^a   Ramirez, N ^a   Gonzalez, R ^a   Valtuille, R ^a   Beresan, H ^a   Hermida, O ^a   Rudolf, G ^a   Marchetta, N ^a   Rano, M ^a   Ramirez, M ^a   Garcia, N ^a   Gillies, A ^a   Jones, B ^a   Pedagogos, E ^a   Walker, R ^a   Talaulikar, G ^a   Bannister, K ^a   Suranyi, M ^a   Kark, A ^a   Roger, S ^a   Kerr, P ^a   Disney, A ^a   Mount, P ^a   Fraenkel, M ^a   Mathew, M ^a   Fassett, R ^a   Jose, M ^a   Hawley, C ^a   Lonergan, M ^a   Mackie, J ^a   Ferrari, P ^a   Menahem, S ^a   Sabto, J ^a   Hutchison, B ^a   Langham, R ^a   Pollock, C ^a   Holzer, H ^a   Oberbauer, R ^a   Arias, I ^a   Graf, H ^a   Mayer, G ^a   Lhotta, K ^a   Neyer, U ^a   Klauser Braun, R ^a   Hoerl, W ^a   Horn, S ^a   Kovarik, J ^a   Kramar, R ^a   Eigner, M ^a   Dhaene, M ^a   Billiouw, J ^a   De Meester, J ^a   Warling, X ^a   Cambier Dwelschauwers, P ^a   Evenepoel, P ^a   Daelemans, R ^a   Dratwa, M ^a   Maes, B ^a   Stolear, J ^a   Dejagere, T ^a   Vanwalleghem, J ^a   Bouman, K ^a   Jadoul, M ^a   Peeters, J ^a   Vanholder, R ^a   Tielemans, C ^a   Donck, J ^a   Almeida, F ^a   de Oliveira, J ^a   Burdmann, E ^a   Garcia, V ^a   Thome, F ^a   Deboni, L ^a   Bregman, R ^a   Lugon, J ^a   Araujo S ^a   Ferreira Filho, S ^a   Daher Ede, F ^a   Baptista, M ^a   Carvalho, A ^a   D'avila, D ^a   Moyses Neto, M ^a   Yu, L ^a   Bastos, M ^a   Lacativa, P ^a   Jorgetti, V ^a   Romao Ede A ^a   da Costa, J C ^a   Pecoits Filho, R ^a   Gordan, P ^a   Salgado, N ^a   Araujo M ^a   Coelho, S ^a   Oliveira, I ^a   Moyses R ^a   Vasconcellos, L ^a   Batista, P ^a   Gross, J ^a   Pedrosa, A ^a   Cournoyer, S ^a   Leblanc, M ^a   Chow, S ^a   Karunakaran, S ^a   Wong, G ^a   Tobe, S ^a   Desmeules, S ^a   Zimmerman, D ^a   Murphy, S ^a   Montambault, P ^a   Donnelly, S ^a   Macrae, J ^a   Culleton, B ^a   Soroka, S ^a   Rabbat, C ^a   Jindal, K ^a   Vasilevsky, M ^a   Michaud, M ^a   Wijeyesinghe, E ^a   Zacharias, J ^a   Lok, C ^a   Muirhead, N ^a   Verrelli, M ^a   Roza, G Da ^a   Sapir, D ^a   Olgaard, K ^a   Daugaard, H ^a   Brandi, L ^a   Jensen, P ^a   Boulechfar, H ^a   Ang, K ^a   Simon, P ^a   Rieu, P ^a   Brunet, P ^a   Touchard, G ^a   Torres, P ^a   Combe, C ^a   Durrbach, A ^a   Ortiz, J ^a   Hannedouche, T ^a   Vela, C ^a   Lionet, A ^a   Ryckelynck, P ^a   Zaoui, P ^a   Choukroun, G ^a   Fessi, H ^a   Lang, P ^a   Stroumza, P ^a   Joly, D ^a   Mousson, C ^a   Laville, M ^a   Dellanna, F ^a   Erley, C ^a   Braun, J ^a   Rambausek, M ^a   Riegel, W ^a   Klingberg, M ^a   Schwertfeger, E ^a   Wizemann, V ^a   Eckardt, K ^a   Reichel, H ^a   Passauer, J ^a   Hubel E ^a   Frischmuth, N ^a   Liebl, R ^a   Fiedler, R ^a   Schwenger, V ^a   Vosskuhler A ^a   Kunzendorf, U ^a   Renders, L ^a   Rattensberger, D ^a   Rump, L ^a   Ketteler, M ^a   Neumayer, H ^a   Zantvoort, F ^a   Stahl, R ^a   Ladanyi, E ^a   Braun, B ^a   Kulcsar, I ^a   Mezei, I ^a   Csiky, B ^a   Rikker, C ^a   Arkossy, O ^a   Berta, K ^a   Szegedi, J ^a   Major, L ^a   Ferenczi, S ^a   Fekete, A ^a   Szabo, T ^a   Zakar, G ^a   Wagner, G ^a   Erdelyine, S ^a   Borbas, B ^a   Eustace, J ^a   Reddan, D ^a   Capasso, G ^a   Locatelli, F ^a   Villa, G ^a   Cozzolino, M ^a   Brancaccio, D ^a   Messa, P ^a   Bolasco, P ^a   Ricciardi, B ^a   Malberti, F ^a   Moriero, E ^a   Cannella, G ^a   Ortalda, V ^a   Stefoni, S ^a   Frasca G ^a   Cappelli, G ^a   Albertazzi, A ^a   Zoccali, C ^a   Farina, M ^a   Elli, A ^a   Avella, F ^a   Ondei, P ^a   Mingardi, G ^a   Errico, R ^a   Losito, A ^a   Di Giulio, S ^a   Pertosa, G ^a   Schena, F ^a   Grandaliano, G ^a   Gesualdo, L ^a   Auricchio, M ^a   Bochicchio Ricardelli, T ^a   Correa Rotter, J ^a   Verastegui F ^a   Pena J ^a   Wong, A ^a   Cruz Valdez, J ^a   Zamora, M ^a   Solis, M ^a   Diaz, M ^a   Flores, M ^a   Sandoval, E ^a   van den Dorpel, M ^a   Brink, H ^a   Van Kuijk, W ^a   Vermeij, C ^a   Gregoor, P ^a   Hagen, E ^a   van der Sande, F ^a   Klinger, M ^a   Nowicki, M ^a   Muszytowski, M ^a   Bidas, K ^a   Bentkowski, W ^a   Wiecek, A ^a   Ksiazek, A ^a   Marczewski, K ^a   Ostrowski, M ^a   Switalski, M ^a   Sulowicz, W ^a   Matuszkiewicz Rowinska, J ^a   Mysliwiec, M ^a   Durlik, M ^a   Rutkowski, B ^a   Macario, F ^a   Carvalho, B ^a   Frazao, J ^a   Machado, D ^a   Weigert, A ^a   Andrusev, A ^a   Khrustalev, O ^a   Zemtchenkov, A ^a   Gurevich, K ^a   Staroselsky, K ^a   Khadikova, N ^a   Rozhinskaya, L ^a   Timokhovskaya, G ^a   Strokov, A ^a   Balkarova, O ^a   Ermolenko, V ^a   Kolmakova, E ^a   Komandenko, M ^a   Timofeev, M ^a   Shilo, V ^a   Shostka, G ^a   Smirnov, A ^a   Anashkin, V ^a   Volgina, G ^a   Domashenko, O ^a   Gurevich, A ^a   Perlin, D ^a   Garcia J ^a   Ribes, E ^a   Piera, E ^a   Lucas, M ^a   Galicia, M ^a   Prados, M ^a   Gonzalez M ^a   Romero, R ^a   de Francisco, A M ^a   Montenegro, J ^a   Santiago, C ^a   Garcia F ^a   de La Ossa, J ^a   Arrieta, J ^a   Pons, J ^a   Martin Malo A ^a   Amigo J ^a   Cases, A ^a   Sterner, G ^a   Jensen, G ^a   Wikstrom B ^a   Jacobson, S ^a   Lund, U ^a   Weiss, L ^a   Stahl A ^a   von Albertini, B ^a   Burnier, M ^a   Meier, P ^a   Martin, P ^a   Uehlinger, D ^a   Dickenmann, M ^a   Yaqoob, M ^a   Zehnder, D ^a   Kalra, P ^a   Padmanabhan, N ^a   Roe, S ^a   Eadington, D ^a   Pritchard, N ^a   Hutchison, A ^a   Davies, S ^a   Wilkie, M ^a   Davies, M ^a   Pai, P ^a   Swift, P ^a   Kwan, J ^a   Goldsmith, D ^a   Tomson, C ^a   Stratton, J ^a   Dasgupta, I ^a   Sarkar, S ^a   Moustafa, M ^a   Gandhi, K ^a   Jamal, A ^a   Galindo Ramos, E ^a   Tuazon, J ^a   Batlle, D ^a   Tucker, K ^a   Schiller Moran, B ^a   Assefi, A ^a   Martinez, C ^a   Samuels, L ^a   Goldman, J ^a   Cangiano Rivera, J ^a   Darwish, R ^a   Lee, M ^a   Topf, J ^a   Kapatkin, K ^a   Baer, H ^a   Kopelman, R ^a   Acharya, M ^a   Tharpe, D ^a   Bernardo, M ^a   Nader, P ^a   Guzman Rivera, J ^a   Pergola, P ^a   Sekkarie, M ^a   Alas, E ^a   Zager, P ^a   Liss, K ^a   Navarro, J ^a   Roppolo, M ^a   Denu Ciocca, C ^a   Kshirsagar, A ^a   El Khatib, M ^a   Kant, K ^a   Scott, D ^a   Murthyr, B ^a   Finkelstein, F ^a   Keightley, G ^a   McCrary, R ^a   Pitone, J ^a   Cavalieri, T ^a   Tsang, A ^a   Pellegrino, B ^a   Schmidt, R ^a   Ahmad, S ^a   Brown, C ^a   Friedman, E ^a   Mittman, N ^a   Fadem, S ^a   Shapiro, W ^a   Reddy, M ^a   Goldberger, S ^a   Woredekal, Y ^a   Agarwal, A ^a   Anger, M ^a   Haque, M ^a   Chidester, P ^a   Kohli, R ^a   Rubinstein, S ^a   Newman, G ^a   Gladish, R ^a   Ayodeji, O ^a   Soman, S ^a   Sprague, S ^a   Hunt, N ^a   Gehr, T ^a   Rizk, D ^a   Warnock, D ^a   Polack, D ^a   Pahl, M ^a   Fischer, D ^a   Dreyer, P ^a   James, G ^a   Husserl, F ^a   Rogers, T ^a   Raff, A ^a   Sedor, J ^a   Silver, M ^a   Smith, M ^a   Steinberg, S ^a   Delgiorno, T ^a   Jones, E ^a   Cunha, P ^a   Cheng, J ^a   Pogue, V ^a   Blumenthal, S ^a   Brown, E ^a   Charytan, C ^a   Buerkert, J ^a   Cook, M ^a   Felsenfeld, A ^a   Tareen, N ^a   Gupta, A ^a   Herman, T ^a   Diamond, S ^a   Hura, C ^a   Laski, M ^a   Maclaurin, J ^a   Plumb, T ^a   Brosnahan, G ^a   Kumar, J ^a   Henriquez, M ^a   Poole, C ^a   Osanloo, E ^a   Matalon, A ^a   Sholer, C ^a   Arfeen, S ^a   Azer, M ^a   Belledonne, M ^a   Gross, M ^a   Dunnigan, E ^a   McConnell, K ^a   Becker, B ^a   Rigolosi, R ^a   Spiegel, D ^a   Stegman, M ^a   Patak, R ^a   Streja, D ^a   Ranjit, U ^a   Youell, T ^a   Wooldridge, T ^a   Stafford, C ^a   Cottiero, R ^a   Weinberg, M ^a   Schonefeld, M ^a   Shahmir, E ^a   Hazzan, A ^a   Ashfaq, A ^a   Bhandari, K ^a   Cleveland, W ^a   Culpepper, M ^a   Golden, J ^a   Lai, L ^a   Lien, Y ^a   Lorica, V ^a   Robertson, J ^a   Malireddi, K ^a   Morse, S ^a   Thakur, V ^a   Israelit, A ^a   Raguram, P ^a   Alfred, H ^a   Weise, W ^a   Al Saghir, F ^a   Shahawy, M El ^a   Rastogi, A ^a   Nissenson, A ^a   Kopyt, N ^a   Lynn, R ^a   Lea, J ^a   McClellan, W ^a   Teredesai, P ^a   Ong, S ^a   Tolkan, S ^a   Sugihara, J ^a   Minga, T ^a   Mehrotra, R ^a   Minasian, R ^a   Bhatia, D ^a   Specter, R ^a   Capelli, J ^a   Sidhu, P ^a   Dalal, S ^a   Dykes, P ^a   Khan, M ^a   Rahim, F ^a   Saklayen, M ^a   Thomas, A ^a   Michael, B ^a   Torres, M ^a   Al Bander, H ^a   Murray, B ^a   Abukurah, A ^a   Gupta, B ^a   Nosrati, S ^a   Raja, R ^a   Zeig, S ^a   Braun, M ^a   Amatya, A ^a   Endsley, J ^a   Sharon, Z ^a   Dolson, G ^a   Dumler, F ^a   Ntoso, K ^a   Rosansky, S ^a   Kumar, N ^a   Gura, V ^a   Thompson, N ^a   Goldfarb, D ^a   Halligan, R ^a   Middleton, J ^a   Widerhorn, A ^a   Arbeit, L ^a   Arruda, J ^a   Crouch, T ^a   Friedman, L ^a   Khokhar, S ^a   Mittleman, J ^a   Light, P ^a   Taparia, B ^a   West, C ^a   Cotton, J ^a   Dhingra, R ^a   Kleinman, L ^a   Arif, F ^a   Lew, S ^a   Nammour, T ^a   Sterrett, J ^a   Williams, M ^a   Ramirez, J ^a   Rubin, J ^a   McCarthy, J ^a   Noble, S ^a   Chaffin, M ^a   Rekhi, A ^a   more..

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

CINACALCET; PARATHYROID HORMONE; PHOSPHATE BINDING AGENT; PLACEBO; VITAMIN D;

ACUTE PANCREATITIS; ADULT; ARTICLE; CALCINOSIS; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CHRONIC KIDNEY DISEASE; CONFIDENCE INTERVAL; CONTROLLED STUDY; CONVULSION; DIARRHEA; DISEASE SEVERITY; DRUG DOSE ESCALATION; DRUG HYPERSENSITIVITY; DRUG WITHDRAWAL; FEMALE; FOLLOW UP; HEART FAILURE; HEART INFARCTION; HEART VENTRICLE ARRHYTHMIA; HEMODIALYSIS; HOSPITALIZATION; HUMAN; HYPERCALCEMIA; HYPERPHOSPHATEMIA; HYPOCALCEMIA; INTENTION TO TREAT ANALYSIS; MAJOR CLINICAL STUDY; MALE; MALIGNANT NEOPLASTIC DISEASE; MORTALITY; MULTICENTER STUDY; NAUSEA AND VOMITING; NEUROLOGIC DISEASE; PERIPHERAL VASCULAR DISEASE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RISK REDUCTION; SECONDARY HYPERPARATHYROIDISM; TOXIC HEPATITIS; TREATMENT DURATION; TREATMENT OUTCOME; UNSTABLE ANGINA PECTORIS;

EID: 84871675923     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMoa1205624     Document Type: Article

References (39)

1. Go AS, Chertow GM, Fan D, McCulloch CE, Hsu CY. Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med 2004;351:1296-305.
2. Foley RN, Murray AM, Li S, et al. Chronic kidney disease and the risk for cardiovascular disease, renal replacement, and death in the United States Medicare population, 1998 to 1999. J Am Soc Nephrol 2005;16:489-95.
3. Nusair MB, Rajprohit N, Alpert MA. Chronic inflammation and coronary atherosclerosis in patients with end-stage renal disease. Cardiorenal Med 2012;2:117-24.
4. Himmelfarb J. Uremic toxicity, oxidative stress and hemodialysis as renal replacement therapy. Semin Dial 2009;22:636-43.
5. Briet M, Burns KD. Chronic kidney disease and vascular remodeling: molecular mechanisms and clinical implications. Clin Sci (Lond) 2012;123:399-416.
6. Rubinger D, Backeroth R, Sapoznikov D. Sympathetic activation and baroreflex function during intradialytic hypertensive episodes. PLoS One 2012;7(5):e36943.
7. Mallamaci F, Tripepi G, Cutrupi S, Malatino LS, Zoccali C. Prognostic value of combined use of biomarkers of inflammation, endothelial dysfunction, and myocardiopathy in patients with ESRD. Kidney Int 2005;67:2330-7.
8. Jourde-Chiche N, Dou L, Cerini C, Dignat-Goerge F, Brunet P. Vascular incompetence in dialysis patients: proteinbound uremic toxins and endothelial dysfunction. Semin Dial 2011;24:327-37.
9. Mezzano D, Tagle R, Panes O, et al. Hemostatic disorder of uremia: the platelet defect, main determinant of the prolonged bleeding time, is correlated with indices of activation of coagulation and fibrinolysis. Thromb Haemost 1996;76:312-21.
10. Fishbane S. Anemia and cardiovascular risk in the patient with kidney disease. Heart Fail Clin 2008;4:401-10.
11. Kidney Disease Improving Global Outcomes (KDIGO) CKD-MBD Work Group. KDIGO clinical practice guideline for the diagnosis, evaluation, prevention, and treatment of chronic kidney disease-mineral and bone disorder (CKD-MBD). Kidney Int Suppl 2009;76:S1-S130.
12. Block GA, Klassen PS, Lazarus JM, Ofsthun N, Lowrie EG, Chertow GM. Mineral metabolism, mortality and morbidity in maintenance hemodialysis. J Am Soc Nephrol 2004;15:2208-18.
13. Floege J, Kim J, Ireland E, et al. Serum iPTH, calcium and phosphorus and the risk of mortality in a European haemodialysis population. Nephrol Dial Transplant 2011;26:1948-55.
14. Kalantar-Zadeh K, Kuwae N, Regidor DL, et al. Survival predictability of time-varying indicators of bone disease in maintenance hemodialysis patients. Kidney Int 2006;70:771-80.
15. Gutiérrez OM, Mannstadt M, Isakova T, et al. Fibroblast growth factor 23 and mortality among patients undergoing hemodialysis. N Engl J Med 2008;359:584-92.
16. Suzuki T, Yonemura K, Maruyama Y, et al. Impact of serum parathyroid hormone concentration and its regulatory factors on arterial stiffness in patients undergoing maintenance hemodialysis. Blood Purif 2004;22:293-7.
17. London GM, Marchais SJ, Guérin AP, Métivier F. Arteriosclerosis, vascular calcifications and cardiovascular disease in uremia. Curr Opin Nephrol Hypertens 2005;14:525-31.
18. Quarles LD, Sherrard DJ, Adler S, et al. The calcimimetic AMG 073 as a potential treatment for secondary hyperparathyroidism of end-stage renal disease. J Am Soc Nephrol 2003;14:575-83.
19. Block GA, Martin KJ, de Francisco AL, et al. Cinacalcet for secondary hyperparathyroidism in patients receiving hemodialysis. N Engl J Med 2004;350:1516-25.
20. Lindberg JS, Culleton B, Wong G, et al. Cinacalcet HCl, an oral calcimimetic agent for the treatment of secondary hyperparathyroidism in hemodialysis and peritoneal dialysis: a randomized, double-blind, multicenter study. J Am Soc Nephrol 2005;16:800-7.
21. Cunningham J, Danese M, Olson K, Klassen P, Chertow GM. Effects of the calcimimetic cinacalcet HCl on cardiovascular disease, fracture, and health-related quality of life in secondary hyperparathyroidism. Kidney Int 2005;68:1793-800.
22. Raggi P, Chertow GM, Block GA, et al. The ADVANCE study: a randomized trial to evaluate the effects of cinacalcet plus low dose vitamin D on vascular calcification in patients on hemodialysis. Nephrol Dial Transplant 2011;26:1327-39.
23. Chertow GM, Pupim LB, Block GA, et al. EVOLVE (Evaluation of Cinacalcet Therapy to Lower Cardiovascular Events): rationale and design of a randomized clinical trial. Clin J Am Soc Nephrol 2007;2:898-905.
24. Chertow GM, Correa-Rotter R, Block GA, et al. Baseline characteristics of subjects enrolled in the Evaluation of Cinacalcet HCl Therapy to Lower Cardiovascular Events (EVOLVE) trial. Nephrol Dial Transplant 2012;27:2872-9.
25. Besarab A, Bolton WK, Browne JK, et al. The effects of normal as compared with low hematocrit values in patients with cardiac disease who are receiving hemodialysis and epoetin. N Engl J Med 1998;339:584-90.
26. Eknoyan G, Beck GJ, Cheung AK, et al. Effect of dialysis dose and membrane flux in maintenance hemodialysis. N Engl J Med 2002;347:2010-9.
27. Wanner C, Krane V, März W, et al. Atorvastatin in patients with type 2 diabetes mellitus undergoing hemodialysis. N Engl J Med 2005;353:238-48. [Erratum, N Engl J Med 2005;353:1640.]
28. Fellström BC, Jardine AG, Schmider RE, et al. Rosuvastatin and cardiovascular events in patients undergoing hemodialysis. N Engl J Med 2009;360:1395-407. [Erratum, N Engl J Med 2010;362:1450.]
29. Baigent C, Landray MJ, Reith C, et al. The effects of lowering LDL cholesterol with simvastatin plus ezetimibe in patients with chronic kidney disease (Study of Heart and Renal Protection): a randomized placebo-controlled trial. Lancet 2011;377:2181-92.
30. Tonelli M, Isles C, Curhan GC, et al. Effect of pravastatin on cardiovascular events in people with chronic kidney disease. Circulation 2004;110:1557-63.
31. Nakamura H, Mizino K, Ohashi Y, et al. Pravastatin and cardiovascular risk in moderate chronic kidney disease. Atherosclerosis 2009;206:512-7.
32. Avram MM, Mittman N, Myint MM, Fein P. Importance of low serum parathyroid hormone as a predictor of mortality in hemodialysis and peritoneal dialysis patients: 24 years of prospective observation. Am J Kidney Dis 2001;38:1351-7.
33. Melamed ML, Eustace JA, Plantinga L, et al. Changes in serum calcium, phosphate, and PTH and the risk of death in incident dialysis patients. Kidney Int 2006;70:351-7.
34. Drechsler C, Krane V, Grootendorst DC, et al. The association between parathyroid hormone and mortality in dialysis patients is modified by wasting. Nephrol Dial Transplant 2009;24:3151-7.
35. Tavazzi L, Maggioni AP, Marchioli R, et al. Effect of n-3 polyunsaturated fatty acids in patients with chronic heart failure (the GISSI-HF trial): a randomized double-blind placebo-controlled clinical trial. Lancet 2008;372:1223-30.
36. O'Connor CM, Whellan DJ, Lee KL, et al. Efficacy and safety of exercise training in patients with chronic heart failure: HF-ACTION randomized controlled trial. JAMA 2009;301:1439-50.
37. Pfeffer MA, Swedberg K, Granger CB, et al. Effects of candesartan on mortality and morbidity in patients with chronic heart failure: the CHARM-Overall programme. Lancet 2003;362:759-66.
38. U.S. Renal Data System. USRDS 2011 annual data report: atlas of chronic kidney disease and end-stage renal disease in the United States. Bethesda, MD: National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, 2011.
39. Chiu YW, Teitelbaum I, Misra M, de Leon EM, Adzize T. Mehrotra R. Pill burden, adherence, hyperphosphatemia and quality of life in maintenance hemodialysis patients. Clin J Am Soc Nephrol 2009;4:1089-96.